APA (7th ed.) Citation

BWK, W., M, L., Y, W., R, S., & M, K. (2021). TGF-β-Induced TMEPAI Promotes Epithelial–Mesenchymal Transition in Doxorubicin-Treated Triple-Negative Breast Cancer Cells via SMAD3 and PI3K/AKT Pathway Alteration. Dove Medical Press.

Chicago Style (17th ed.) Citation

BWK, Wardhani, Louisa M, Watanabe Y, Setiabudy R, and Kato M. TGF-β-Induced TMEPAI Promotes Epithelial–Mesenchymal Transition in Doxorubicin-Treated Triple-Negative Breast Cancer Cells via SMAD3 and PI3K/AKT Pathway Alteration. Dove Medical Press, 2021.

MLA (8th ed.) Citation

BWK, Wardhani, et al. TGF-β-Induced TMEPAI Promotes Epithelial–Mesenchymal Transition in Doxorubicin-Treated Triple-Negative Breast Cancer Cells via SMAD3 and PI3K/AKT Pathway Alteration. Dove Medical Press, 2021.